Travere Therapeutics
TVTX
TVTX
149 hedge funds and large institutions have $1.56B invested in Travere Therapeutics in 2021 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 57 increasing their positions, 37 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 137 → 149 (+12)
1.52% more ownership
Funds ownership: 102.44% → 103.95% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
149
Holding in Top 10
1
Calls
$3.07M
Puts
$2.76M
Top Buyers
| 1 | +$60.9M | |
| 2 | +$58.8M | |
| 3 | +$42.4M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$26.4M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$24.6M |
Top Sellers
| 1 | -$23.6M | |
| 2 | -$20.2M | |
| 3 | -$13.8M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$12.9M |
| 5 |
Millennium Management
New York
|
-$7.28M |